Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Heidi Bertheussen"'
Autor:
Laure Gossec, Maarten de Wit, Jette Primdahl, Paul Studenic, Muriel Elhai, Heidi Bertheussen, Diego Benavent, Codruța Zăbălan, Krystel Aouad
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Objective The inclusion of patient research partners (PRPs) in research projects is increasingly recognised and recommended in rheumatology. The level of involvement of PRPs in translational research in rheumatology remains unknown, while in randomis
Externí odkaz:
https://doaj.org/article/50b5f3e81e164f1d91993f79ed56e958
Autor:
Oliver FitzGerald, Frank Behrens, Anne Barton, Heidi Bertheussen, Bruno Boutouyrie-Dumont, Laura Coates, Owen Davies, Maarten de Wit, Filippo Fagni, Carl S. Goodyear, Robert Gurke, Lisa Hahnefeld, Christine Huppertz, Vassilios Ioannidis, Mark Ibberson, Arnon Katz, Maximilian Klippstein, Michaela Koehm, Shimon Korish, Sina Mackay, David A. Martin, Denis O’Sullivan, Khadijah Patel, Stefan Rueping, Georg Schett, Klaus Scholich, Jochen M. Schwenk, Stefan Siebert, David Simon, Arani Vivekanantham, Stephen R. Pennington
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 15 (2023)
Achieving a good outcome for a person with Psoriatic Arthritis (PsA) is made difficult by late diagnosis, heterogenous clinical disease expression and in many cases, failure to adequately suppress inflammatory disease features. Single-centre studies
Externí odkaz:
https://doaj.org/article/a667e6ccef804442bb02abacbd1a08bf
Autor:
Lihi Eder, Ashish J. Mathew, Philippe Carron, Heidi Bertheussen, Juan D. Cañete, May Azem, Andrea Delle Sedie, Carlo Salvarani, Roberto Ranza, Ashley Elliott, Anthony Turkiewicz, Ricardo Acayaba de Toledo, Hulya Bukulmez, Maria S. Stoenoiu, Arthur M. Mandelin, Michaela Koehm, Chris A. Lindsay, Evan Siegel, Philip J. Mease
Publikováno v:
JOURNAL OF RHEUMATOLOGY
ObjectiveEnthesitis is a key pathological and clinical feature of psoriatic arthritis (PsA) in children and adults. Enthesitis is typically assessed clinically using several validated enthesitis scoring systems that have been used in clinical trials.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3c3cf5bd44323e300c6fc7590c3b93
https://pubmed.ncbi.nlm.nih.gov/36319005
https://pubmed.ncbi.nlm.nih.gov/36319005
Autor:
Daniel Aletaha, Ming-Ann Hsu, Joseph F. Merola, Pamela M Young, Lara Fallon, Heidi Bertheussen, M. Elaine Husni, Claire Ervin, Roberto Ranza, T. Michelle Brown, R. Lippe, Joseph C. Cappelleri
Publikováno v:
Patient Preference and Adherence. 14:949-961
Objective Qualitative research exploring patient preferences regarding the mode of treatment administration for psoriatic arthritis (PsA) is limited. We report patient preferences and their reasons across PsA treatment modes. Methods In this global,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b32f8e148a84a9426f04cb1d5fd9737a
https://doi.org/10.2147/ppa.s242336
https://doi.org/10.2147/ppa.s242336
Autor:
Aurélie Najm, Gerd-Rüdiger Burmester, Xavier Mariette, Benjamin Terrier, Dennis McGonagle, Heidi Bertheussen, Pier Luigi Meroni, Gabriele De Marco, Hendrik Schulze-Koops, César Magro-Checa, Iain B. McInnes, Alessia Alunno, Manuel Ramos-Casals, Sander W. Tas, John D. Isaacs, Luca Quartuccio, Javier Rodríguez Carrio, Athimalaipet V Ramanan, Isabelle Koné-Paut, Olivier Hermine, Tanja Stamm, Roberto Giacomelli, Pedro Machado, Francesco Carubbi
Publikováno v:
Annals of the rheumatic diseases. BMJ Publishing Group
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases
ObjectivesTo update the EULAR points to consider (PtCs) on the use of immunomodulatory therapies in COVID-19.MethodsAccording to the EULAR standardised operating procedures, a systematic literature review up to 14 July 2021 was conducted and followed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35391128d2ed2816c5bfaa8c68bcc8bd
Autor:
Manuel Ramos-Casals, Pier Luigi Meroni, Tanja Stamm, Roberto Giacomelli, Iain B. McInnes, D. McGonagle, V. R. Athimalaipet, César Magro-Checa, J. Rodríguez-Carrio, G. De Marco, Pedro Machado, Sander W. Tas, Francesco Carubbi, G.-R. Burmester, Olivier Hermine, John D. Isaacs, Xavier Mariette, Benjamin Terrier, Aurélie Najm, Alessia Alunno, H. Schultze-Koops, Luca Quartuccio, Heidi Bertheussen, Isabelle Koné-Paut
Publikováno v:
Revue du Rhumatisme (Ed. Francaise : 1993)
Introduction Les formes sévères de COVID-19 comportent à une hyperinflammation systémique intense ; ce qui a justifié des essais thérapeutiques avec des immunomodulateurs régulièrement utilisés chez les patients atteints de maladies systémi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0c4f20d4884681679e2e793a277b557
https://doi.org/10.1016/j.rhum.2021.10.349
https://doi.org/10.1016/j.rhum.2021.10.349
Autor:
Tanja Stamm, Roberto Giacomelli, Manuel Ramos-Casals, César Magro-Checa, Iain B. McInnes, Heidi Bertheussen, Xavier Mariette, Isabelle Koné-Paut, Pier Luigi Meroni, Alessia Alunno, Luca Quartuccio, Pedro Machado, John D. Isaacs, Athimalaipet V Ramanan, Francesco Carubbi, Javier Rodríguez Carrio, Benjamin Terrier, Dennis McGonagle, Hendrik Schulze-Koops, Olivier Hermine, Gerd R Burmester, Aurélie Najm, Gabriele De Marco, Sander W. Tas
Publikováno v:
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
Universidad de las Islas Baleares
Annals of the rheumatic diseases, 80(6):219724, 698-706. BMJ Publishing Group
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Annals of the Rheumatic Diseases
RUO. Repositorio Institucional de la Universidad de Oviedo
Universidad de las Islas Baleares
Annals of the rheumatic diseases, 80(6):219724, 698-706. BMJ Publishing Group
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Annals of the Rheumatic Diseases
This work was funded by European League Against Rheumatism (CLI122). PMM is supported by the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC). JDI is a NIHR Senior Investigator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a06e80b7bab94a9d7c4aad6883337e
http://hdl.handle.net/10651/59324
http://hdl.handle.net/10651/59324
Autor:
Philip J. Mease, Lori Schick, Pil Højgaard, Ana Maria Orbai, Vibeke Strand, Walter P. Maksymowych, Dafna D. Gladman, Alexis Ogdie, Richard Holland, Maria Antonietta D'Agostino, Laura C. Coates, William Tillett, Robin Christensen, Niti Goel, Anna Antony, Heidi Bertheussen, Ying Ying Leung
Publikováno v:
Antony, A, Holland, R, D'Agostino, M A, Maksymowych, W P, Bertheussen, H, Schick, L, Goel, N, Ogdie, A, Orbai, A M, Højgaard, P, Coates, L C, Strand, V, Gladman, D D, Christensen, R, Leung, Y Y, Mease, P & Tillett, W 2021, ' Measurement properties of radiographic outcome measures in Psoriatic Arthritis : A systematic review from the GRAPPA-OMERACT initiative ', Seminars in Arthritis and Rheumatism, vol. 51, no. 2, pp. 367-386 . https://doi.org/10.1016/j.semarthrit.2021.01.008
Background Structural damage is as an important outcome in the Psoriatic Arthritis (PsA) Core Domain Set and its assessment is recommended at least once in the development of a new drug. Objectives To conduct a systematic review (SR) to identify stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e804d35ca610886a8efb1c0eb86ebf4
https://pubmed.ncbi.nlm.nih.gov/33601193
https://pubmed.ncbi.nlm.nih.gov/33601193
Autor:
Robert Landewé, Douglas J. Veale, Josef S Smolen, Désirée van der Heijde, Filip Van den Bosch, Daniel Aletaha, Heidi Bertheussen, Maarten de Wit, Peter V. Balint, Santiago Rodrigues Manica, Laure Gossec, Andreas Kerschbaumer, Wolf-Henning Boehncke, Rik Lories, Gerd R Burmester, Denis Poddubnyy, Dennis McGonagle, Nemanja Damjanov, Georg Schett, Helena Marzo-Ortega, Jette Primdahl, Iain B. McInnes, Tore K Kvien, Andra Balanescu, Maxime Dougados, Xenofon Baraliakos, Juan D. Cañete, Tue Wenzel Kragstrup
Publikováno v:
Annals of the Rheumatic Diseases, 79(6), 700-712. BMJ PUBLISHING GROUP
Annals of the rheumatic diseases, 79(6), S700-S712. BMJ Publishing Group
Gossec, L, Baraliakos, X, Kerschbaumer, A, de Wit, M, McInnes, I, Dougados, M, Primdahl, J, McGonagle, D G, Aletaha, D, Balanescu, A, Balint, P V, Bertheussen, H, Boehncke, W-H, Burmester, G R, Canete, J D, Damjanov, N S, Kragstrup, T W, Kvien, T K, Landewé, R B M, Lories, R J U, Marzo-Ortega, H, Poddubnyy, D, Rodrigues Manica, S A, Schett, G, Veale, D J, Van den Bosch, F E, van der Heijde, D & Smolen, J S 2020, ' EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update ', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. 700-712 . https://doi.org/10.1136/annrheumdis-2020-217159
Annals of the Rheumatic Diseases
Gossec, L, Baraliakos, X, Kerschbaumer, A, de Wit, M, McInnes, I, Dougados, M, Primdahl, J, McGonagle, D G, Aletaha, D, Balanescu, A, Balint, P V, Bertheussen, H, Boehncke, W H, Burmester, G R, Canete, J D, Damjanov, N S, Kragstrup, T W, Kvien, T K, Landewé, R B M, Lories, R J U, Marzo-Ortega, H, Poddubnyy, D, Rodrigues Manica, S A, Schett, G, Veale, D J, Van den Bosch, F E, van der Heijde, D & Smolen, J S 2020, ' EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update ', Annals of the rheumatic diseases, vol. 79, no. 6, pp. 700-712 . https://doi.org/10.1136/annrheumdis-2020-217159
ANNALS OF THE RHEUMATIC DISEASES
Annals of the Rheumatic Diseases, Vol. 79, No 6 (2020) pp. 700-712
Annals of the rheumatic diseases, 79(6), S700-S712. BMJ Publishing Group
Gossec, L, Baraliakos, X, Kerschbaumer, A, de Wit, M, McInnes, I, Dougados, M, Primdahl, J, McGonagle, D G, Aletaha, D, Balanescu, A, Balint, P V, Bertheussen, H, Boehncke, W-H, Burmester, G R, Canete, J D, Damjanov, N S, Kragstrup, T W, Kvien, T K, Landewé, R B M, Lories, R J U, Marzo-Ortega, H, Poddubnyy, D, Rodrigues Manica, S A, Schett, G, Veale, D J, Van den Bosch, F E, van der Heijde, D & Smolen, J S 2020, ' EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update ', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. 700-712 . https://doi.org/10.1136/annrheumdis-2020-217159
Annals of the Rheumatic Diseases
Gossec, L, Baraliakos, X, Kerschbaumer, A, de Wit, M, McInnes, I, Dougados, M, Primdahl, J, McGonagle, D G, Aletaha, D, Balanescu, A, Balint, P V, Bertheussen, H, Boehncke, W H, Burmester, G R, Canete, J D, Damjanov, N S, Kragstrup, T W, Kvien, T K, Landewé, R B M, Lories, R J U, Marzo-Ortega, H, Poddubnyy, D, Rodrigues Manica, S A, Schett, G, Veale, D J, Van den Bosch, F E, van der Heijde, D & Smolen, J S 2020, ' EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2019 update ', Annals of the rheumatic diseases, vol. 79, no. 6, pp. 700-712 . https://doi.org/10.1136/annrheumdis-2020-217159
ANNALS OF THE RHEUMATIC DISEASES
Annals of the Rheumatic Diseases, Vol. 79, No 6 (2020) pp. 700-712
ObjectiveTo update the European League Against Rheumatism (EULAR) recommendations for the pharmacological treatment of psoriatic arthritis (PsA).MethodsAccording to the EULAR standardised operating procedures, a systematic literature review was follo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a77d4a94d305a2a0200306e83597745
https://ard.bmj.com/content/79/6/700.1.info
https://ard.bmj.com/content/79/6/700.1.info
Autor:
R. Mcdonald, M.E. Husni, Oliver FitzGerald, Heidi Bertheussen, D.A.W.M. van der Windt, Suzanne M. Dolwick Grieb, Niti Goel, Jeffrey Chau, Enrique R. Soriano, Lihi Eder, M. de Wit, Laura C. Coates, Luis Daniel Mazzuoccolo, Lori Schick, Ingrid Steinkoenig, Dafna D. Gladman, Nadia Corp, P S Helliwell, Alexis Ogdie, D. Laheru, Kristina Callis-Duffin, A. Kavanaugh, Dennis O’Sullivan, W. Olsder, Amit Garg, Christine A. Lindsay, Deepak R. Jadon, John Latella, C. Barbosa Campanholo, D. Fernandez, P. J. Mease, Ying Ying Leung, A. Katz, Ennio Lubrano
Publikováno v:
Annals of the Rheumatic Diseases. 80:139-140
Background:Since the 2015 GRAPPA treatment recommendations were published, therapeutic options and management strategies for psoriatic arthritis (PsA) have advanced considerably.Objectives:The goal of the GRAPPA recommendations update is to develop h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22a86725b69ee0af913f34d70d8bc519
https://doi.org/10.1136/annrheumdis-2021-eular.4091
https://doi.org/10.1136/annrheumdis-2021-eular.4091